Van Scoy R E, Wilkowske C J
Division of Infectious Diseases and Internal Medicine, Mayo Clinic.
Mayo Clin Proc. 1987 Dec;62(12):1129-36. doi: 10.1016/s0025-6196(12)62507-5.
Antituberculous agents have radically improved the prognosis of patients with active tuberculosis. Generally, 6-month and 9-month regimens have been successful, and surgical therapy is rarely necessary. Extrapulmonary tuberculosis should be managed with the drug regimens outlined for pulmonary tuberculosis. The major cause of therapeutic failure is poor compliance of the patient in taking the medication regularly. The second major cause of treatment failure is resistance of tubercle bacilli to the antimicrobial agents used. When treatment failure is apparent, careful reassessment by physicians experienced in the treatment of tuberculosis is indicated. A single drug should never be added to a failing regimen. For prophylaxis, isoniazid, given for 6 to 12 months, is effective in most cases.
抗结核药物已从根本上改善了活动性肺结核患者的预后。一般来说,6个月和9个月的治疗方案已取得成功,很少需要手术治疗。肺外结核应采用针对肺结核概述的药物治疗方案。治疗失败的主要原因是患者未规律服药依从性差。治疗失败的第二个主要原因是结核杆菌对所用抗菌药物产生耐药性。当明显出现治疗失败时,建议由治疗结核病经验丰富的医生进行仔细重新评估。绝不应在失败的治疗方案中加用单一药物。对于预防,服用6至12个月的异烟肼在大多数情况下是有效的。